Decision modeling of risks in pharmaceutical supply chains

Managing risks is becoming a highly focused activity in the health service sector. In particular, due to the complex nature of processes in the pharmaceutical industry, several risks have been associated to its supply chains. The purpose of this paper is to identify and analyze the risks occurring in the supply chains of the pharmaceutical industry and propose a decision model, based on the Analytical Hierarchy Process (AHP) method, for evaluating risks in pharmaceutical supply chains (PSCs).,The proposed model was developed based on the Delphi method and AHP techniques. The Delphi method helped to select the relevant risks associated to PSCs. A total of 16 sub risks within four main risks were identified through an extensive review of the literature and by conducting a further investigation with experts from five pharmaceutical companies in Bangladesh. AHP contributed to the analysis of the risks and determination of their priorities.,The results of the study indicated that supply-related risks such as fluctuation in imports arrival, lack of information sharing, key supplier failure and non-availability of materials should be prioritized over operational, financial and demand-related risks.,This work is one of the initial contributions in the literature that focused on identifying and evaluating PSC risks in the context of Bangladesh. This research work can assist practitioners and industrial managers in the pharmaceutical industry in taking proactive action to minimize its supply chain risks. To the end, the authors performed a sensitivity analysis test, which gives an understanding of the stability of ranking of risks.

[1]  Z. Ghazali,et al.  A Framework to Enhance Supply Chain Resilience The Case of Malaysian Pharmaceutical Industry , 2014 .

[2]  S. Disney,et al.  On bullwhip in supply chains--historical review, present practice and expected future impact , 2006 .

[3]  Jennifer Blackhurst,et al.  The Severity of Supply Chain Disruptions: Design Characteristics and Mitigation Capabilities , 2007, Decis. Sci..

[4]  J. Darling,et al.  An analysis of the formulation of strategic alliances: a focus on the pharmaceutical industry , 1999 .

[5]  A. Rogachev.  Enterprise Risk Management In a Pharmaceutical Company , 2008 .

[6]  B. Gaudenzi,et al.  Managing risks in the supply chain using the AHP method , 2006 .

[7]  Gonca Tuncel,et al.  Risk assessment and management for supply chain networks: A case study , 2010, Comput. Ind..

[8]  Orrin Cooper,et al.  An orders-of-magnitude AHP supply chain risk assessment framework , 2016 .

[9]  V. Tummala,et al.  Assessing and Managing Risks Using the Supply Chain Risk Management Process (SCRMP) , 2011 .

[10]  J. Murry,et al.  Delphi: A Versatile Methodology for Conducting Qualitative Research , 2017 .

[11]  Sachin Kumar Mangla,et al.  Decision Modeling Approach for Eco-Driven Flexible Green Supply Chain , 2015 .

[12]  M. Quaddus,et al.  Supply chain risk management (SCRM): a case study on the automotive and electronic industries in Brazil , 2009 .

[13]  Liz Breen,et al.  A Preliminary Examination of Risk in the Pharmaceutical Supply Chain (PSC) in the National Health Service (NHS) , 2008 .

[14]  Matloub Hussain,et al.  Analysis of the bullwhip effect with order batching in multi‐echelon supply chains , 2011 .

[15]  Jennifer Blackhurst,et al.  A model for inbound supply risk analysis , 2006, Comput. Ind..

[16]  Ewa J. Kleczyk, PhD.  Risk Management in the Development of New Products in the Pharmaceutical Industry , 2011 .

[17]  Pradeep Kumar,et al.  An integrated methodology of FTA and fuzzy AHP for risk assessment in green supply chain , 2015 .

[18]  Mincheol Kim,et al.  Application of Delphi-AHP methods to select the priorities of WEEE for recycling in a waste management decision-making tool. , 2013, Journal of environmental management.

[19]  Rosaria de F. S. M. Russo,et al.  Criteria in AHP: A Systematic Review of Literature , 2015, ITQM.

[20]  A. Ghaffar,et al.  Access to medicines from a health system perspective , 2012, Health policy and planning.

[21]  Krsto Pandza,et al.  Absorptive capacity in European manufacturing: a Delphi study , 2007, Ind. Manag. Data Syst..

[22]  Chin-Tsai Lin,et al.  An application of AHP and sensitivity analysis for selecting the best slicing machine , 2007, Comput. Ind. Eng..

[23]  Frank Y. Chen,et al.  Quantifying the Bullwhip Effect in a Simple Supply Chain: The Impact of Forecasting, Lead Times, and Information.: The Impact of Forecasting, Lead Times, and Information. , 2000 .

[24]  O. Khan,et al.  Risk and supply chain management: creating a research agenda , 2007 .

[25]  Rassoul Dinarvand,et al.  Pharmaceutical supply chain risks: a systematic review , 2013, DARU Journal of Pharmaceutical Sciences.

[26]  Xiaochuan Yang,et al.  Quality risk management for pharmaceutical manufacturing: The role of process modeling and simulations , 2017 .

[27]  K. Eisenhardt.  Building theories from case study research , 1989, STUDI ORGANIZZATIVI.

[28]  Keming Zhang,et al.  A new risk assessment model for agricultural products cold chain logistics , 2017, Ind. Manag. Data Syst..

[29]  C. Vașar,et al.  Risk Variables in Wind Power Supply Chain , 2014 .

[30]  A. Abdallah.  Global Pharmaceutical Supply Chain: A Quality Perspective , 2013 .

[31]  Heiko A. Gracht,et al.  A Delphi-based risk analysis — Identifying and assessing future challenges for supply chain security in a multi-stakeholder environment , 2013 .

[32]  D. Ross-Degnan,et al.  Treatment of Febrile illness with artemisinin combination therapy: prevalence and predictors in five African household surveys , 2015, Journal of pharmaceutical policy and practice.

[33]  Eugenio Cinquemani,et al.  Validation methods for population models of gene expression dynamics , 2016 .

[34]  Khalid Bachkar,et al.  MANAGING RISK IN PHARMACEUTICAL GLOBAL SUPPLY CHAIN OUTSOURCING: APPLYING ANALYTIC HIERARCHY PROCESS MODEL , 2009 .

[35]  P. Finch.  Supply chain risk management , 2004 .

[36]  Ahmad Alibabaei,et al.  Information flow in the pharmaceutical supply chain , 2015, Iranian journal of pharmaceutical research : IJPR.

[37]  Rassoul Dinarvand,et al.  Pharmaceutical supply chain risk assessment in Iran using analytic hierarchy process (AHP) and simple additive weighting (SAW) methods , 2015, Journal of Pharmaceutical Policy and Practice.

[38]  B. Gammelgaard,et al.  Managing paradoxical tensions during the implementation of Lean capabilities for improvement , 2016 .

[39]  Ali Diabat,et al.  Using AHP to evaluate barriers in adopting sustainable consumption and production initiatives in a supply chain , 2016 .

[40]  C. Blome,et al.  Supply Chain Risk Management in Financial Crises – A Multiple Case-Study Approach , 2011 .

[41]  Lhoussaine Ouabouch,et al.  Analysing Supply Chain Risk Factors: A Probability-Impact Matrix Applied to Pharmaceutical Industry , 2013 .

[42]  A. Strauss,et al.  The discovery of grounded theory: strategies for qualitative research aldine de gruyter , 1968 .

[43]  D. Ross-Degnan,et al.  Access to care and medicines, burden of health care expenditures, and risk protection: results from the World Health Survey. , 2011, Health policy.

[44]  S. Frosdick.  The techniques of risk analysis are insufficient in themselves , 1997 .

[45]  Xuan Yu,et al.  Pharmaceutical supply chain in China: current issues and implications for health system reform. , 2010, Health policy.

[46]  J. R. Carter,et al.  An analysis of supply risk assessment techniques , 2004 .

[47]  Walid Cheffi,et al.  Green supply chain performance measurement using the analytic hierarchy process: a comparative analysis of manufacturing organisations , 2013 .

[48]  Robert J. Vokurka,et al.  Delphi study on supply chain flexibility , 2005 .

[49]  Sally A. Miller,et al.  USE OF THE DELPHI EXPERT ELICITATION TECHNIQUE TO RANK FOOD SAFETY RISKS IN GREENHOUSE TOMATO PRODUCTION , 2015 .

[50]  Hau L. Lee,et al.  Mitigating supply chain risk through improved confidence , 2004 .

[51]  Navid Sahebjamnia,et al.  An enhanced risk assessment framework for business continuity management systems , 2016 .

[52]  Ralf W. Seifert,et al.  Building up Resilience in a Pharmaceutical Supply Chain through Inventory, Dual Sourcing and Agility Capacity , 2017 .

[53]  Chunguang Bai,et al.  An implementation path for green information technology systems in the Ghanaian mining industry , 2017 .

[54]  F. Zaini,et al.  Overexpression of aldo-keto-reductase in azole-resistant clinical isolates of Candida glabrata determined by cDNA-AFLP , 2013, DARU Journal of Pharmaceutical Sciences.

[55]  Natalie Privett,et al.  The top ten global health supply chain issues: Perspectives from the field , 2014 .

[56]  T. Hartpulugil,et al.  Conceptual framework for potential implementations of multi criteria decision making (MCDM) methods for design quality assessment , 2011 .

[57]  Sally A. Miller,et al.  Delphi expert elicitation to prioritize food safety management practices in greenhouse production of tomatoes in the United States , 2017 .

[58]  Shi-Ming Huang,et al.  Critical factors in adopting a knowledge management system for the pharmaceutical industry , 2005, Ind. Manag. Data Syst..

[59]  Gabriela Prostean,et al.  Assessing Risk Factors in Collaborative Supply Chain with the Analytic Hierarchy Process (AHP) , 2014 .

[60]  P. Rao,et al.  Do green supply chains lead to competitiveness and economic performance , 2005 .

[61]  S. Mangla,et al.  Risk analysis in green supply chain using fuzzy AHP approach: A case study , 2015 .

[62]  J. K. Jha,et al.  A quantitative risk assessment methodology and evaluation of food supply chain , 2017 .

[63]  Martin Nowack,et al.  Review of Delphi-Based Scenario Studies: Quality and Design Considerations , 2011 .

[64]  Abdelaziz Berrado,et al.  Evaluating outsourcing risks in the pharmaceutical supply chain: Case of a multi-criteria combined fuzzy AHP-PROMETHEE approach , 2016 .

[65]  Christian L. Rossetti,et al.  Forces, trends, and decisions in pharmaceutical supply chain management , 2011 .

[66]  V. Tummala,et al.  Assessing supply chain risks with the analytic hierarchy process: Providing decision support for the offshoring decision by a US manufacturing company , 2008 .

[67]  Satyendra Kumar Sharma,et al.  Identification and assessment of supply chain risk: development of AHP model for supply chain risk prioritisation , 2012 .

[68]  J. M. Soon,et al.  A Delphi-based approach to developing and validating a farm food safety risk assessment tool by experts , 2012, Expert Syst. Appl..

[69]  J. Mentzer,et al.  Global supply chain risk management strategies , 2008 .

[70]  Richard D. Metters,et al.  Quantifying the bullwhip effect in supply chains , 1997 .

[71]  Harun Resit Yazgan,et al.  Demand Forecasting In Pharmaceutical Industry Using Neuro-Fuzzy Approach , 2014 .

[72]  Panos Kouvelis,et al.  Supply Chain Management Research and Production and Operations Management: Review, Trends, and Opportunities , 2006 .

[73]  K. Govindan,et al.  Barriers analysis for green supply chain management implementation in Indian industries using analytic hierarchy process , 2014 .

[74]  Sachin Kumar Mangla,et al.  Flexible Decision Modeling for Evaluating the Risks in Green Supply Chain Using Fuzzy AHP and IRP Methodologies , 2015 .

[75]  Christopher S. Tang.  Perspectives in supply chain risk management , 2006 .

[76]  Michael Mitchell,et al.  Risk Management in the Pharmaceutical Product Development Process , 2008, Journal of Pharmaceutical Innovation.

[77]  R. Uthayakumar,et al.  Pharmaceutical supply chain and inventory management strategies: Optimization for a pharmaceutical company and a hospital , 2013 .

[78]  Habib Chabchoub,et al.  A combined approach for supply chain risk management: description and application to a real hospital pharmaceutical case study , 2014 .

[79]  S. Gopinath,et al.  Investigation of Supply Chain Risk in the Indian Pharmaceutical Industry: A Case Study , 2011 .

[80]  Suzanne D. Pawlowski,et al.  The Delphi method as a research tool: an example, design considerations and applications , 2004, Inf. Manag..

[81]  A. E. Mhamedi,et al.  An approach to risk Assessment for Outsourcing Logistics: Case of Pharmaceutical Industry , 2016 .

[82]  Dinesh Kumar,et al.  A combined approach using AHP and DEMATEL for evaluating success factors in implementation of green supply chain management in Indian manufacturing industries , 2016 .

[83]  Omkarprasad S. Vaidya,et al.  Study of Emerging Issues in Supply Risk Management in India , 2012 .

[84]  Chandra Prakash Garg,et al.  An integrated framework for sustainable supplier selection and evaluation in supply chains , 2017 .

[85]  Sarah Root,et al.  Supply chain design considering correlated failures and inspection in pharmaceutical and food supply chains , 2017, Comput. Ind. Eng..

[86]  Kevin P. Scheibe,et al.  Supplier Risk Assessment and Monitoring for the Automotive Industry , 2008 .

[87]  Stephan M. Wagner,et al.  Supplier default dependencies: Empirical evidence from the automotive industry , 2009, Eur. J. Oper. Res..

[88]  D. Holdford,et al.  Understanding the dynamics of the pharmaceutical market using a social marketing framework , 2005 .

[89]  Thomas L. Saaty,et al.  Multicriteria Decision Making: The Analytic Hierarchy Process: Planning, Priority Setting, Resource Allocation , 1990 .

[90]  Young Hoon Kwak,et al.  Risk management framework for pharmaceutical research and development projects , 2008 .

[91]  Promoting transparency, accountability, and access through a multi-stakeholder initiative: lessons from the medicines transparency alliance , 2017, Journal of pharmaceutical policy and practice.